Pathology of the hereditary colorectal carcinoma

Hamilton SR et al (2000) Carcinoma of colon and rectum. In: Hamilton SR, Aaltonen LA (eds) Pathology and genetics tumours of the digestive system. WHO Classification of Tumours. IARC Press, Lyon, pp 105–119 Burgart LJ (2005) Testing for defective mismatch repair in colorectal carcinoma. A practical guide. Arch Pathol Lab Med 129:1385–1389 Samowitz WS, Curtin K, Herrick J et al (2001) The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer. Gastroenterology 121:830–838 Boland CR (2006) Decoding hereditary colorectal cancer. N Engl J Med 354:2815–2817 Jass JR (2006) Hereditary non-polyposis colorectal cancer: the rise and fall of a confusing term. World J Gastroenterol 12:4943–4950 Lindor NM, Rabe K, Petersen GM et al (2005) Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA 293:1979–1985 Lynch HT, Boland CR et al (2006) Phenotypic and genotypic heterogeneity in the Lynch syndrome: diagnostic, surveillance and management implications. Eur J Hum Genet 14:390–402 De Felice C, Latini G, Bianciardi A et al (2003) Abnormal vascular network complexity: a new phenotypic marker in hereditary non-polyposis colorectal cancer syndrome. Gut 52:1764–1767 Winawer S, Fletcher R et al (2003) Gastrointestinal consortium panel. Colorectal cancer screening and surveillance: clinical guidelines and rationale – update based on new evidence. Gastroenterology 124:544–560 Dunlop MG, Gastroenterology. BSf, Ireland. AoCfGBa (2003) Guidance on gastrointestinal surveillance for hereditary non-polyposis colorectal cancer, familial adenomatous polypolis, juvenile polyposis, and Peutz-Jeghers syndrome. Gut 51(S5):21–27 Jarvinen HJ, Aarnio M, Mustonen H et al (2000) Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 118:829–834 Mecklin JP, Jarvinen HJ (1993) Treatment and follow-up strategies in hereditary nonpolyposis colorectal carcinoma. Dis Colon Rectum 36:927–929 Davila RE, Rajan E, Baron TH et al (2006) Standards of Practice Committee, American Society for Gastrointestinal Endoscopy. ASGE guideline: colorectal cancer screening and surveillance. Gastrointest Endosc 63:546–557 Rex DK, Cutler CS, Lemmel GT et al (1997) Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology 112:24–28 Hixson LJ, Fennerty MB, Sampliner RE et al (1990) Prospective study of the frequency and size distribution of polyps missed by colonoscopy. J Natl Cancer Inst 82:1769–1772 Hixson LJ, Fennerty MB, Sampliner RE et al (1991) Prospective blinded trial of the colonoscopic miss-rate of large colorectal polyps. Gastrointest Endosc 37:125–127 Lecomte T, Cellier C, Meatchi T et al (2005) Chromoendoscopic colonoscopy for detecting preneoplastic lesions in hereditary nonpolyposis colorectal cancer syndrome. Clin Gastroenterol Hepatol 3:897–902 Hurlstone DP, Karajeh M, Cross SS et al (2005) The role of high-magnification-chromoscopic colonoscopy in hereditary nonpolyposis colorectal cancer screening: a prospective “back-to-back” endoscopic study. Am J Gastroenterol 100:2167–2173 Saitoh Y, Pasricha PJ, West AB et al (2001) Prevalence and distinctive biological features of flat and colorectal adenomas in a North American population. Gastroenterology 120:1657–1665 Hampel H, Frankel W, Panescu J et al (2006) Screeening for Lynch syndrome (Hereditary Nonpolyposis Colorectal Cancer) among endometrial cancer patients. Cancer Res 66:7810–7817 Ponti G, Losi L, Di Gregorio C et al (2005) Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas. Cancer 103:1018–1025 Peltomaki P, Vasen H, Jass JR (2000) Hereditary nonpolyposis colorectal cancer. In: Hamilton SR, Aaltonen LA (eds) Pathology and genetics tumours of the digestive system. WHO Classification of Tumours. IARC Press, Lyon, pp 126–129 Umar A, Boland CR, Terdiman JP et al (2004) Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96:261–268 Alexander J, Watanabe T, Wu TT et al (2001) Histopathological identification of colon cancer with microsatellite instability. Am J Pathol 158:527–535 Jass JR (2004) Role of the pathologist in the diagnosis of hereditary non-polyposis colorectal cancer. Dis Markers 20:215–224 Jessurun J, Romero-Guadarrama M, Manivel JC (1999) Medullary adenocarcinoma of the colon: clinicopathologic study of 11 cases. Hum Pathol 30:843–848 Muller W, Burgart LJ, Krause-Paulus R et al and the ICG-HNPCC (International Collaborative Group) (2001) The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC) – results of an international collaborative study. Fam Cancer 1:87–92 Young J, Simms LA, Biden KG et al (2001) Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis. Am J Pathol 159:2107–2116 Weisenberger DJ, Siegmund KD, Campan M et al (2006) CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 38:787–793 Domingo E, Laiho P, Ollikainen M et al (2004) BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing. J Med Genet 41:664–668 Nicolaides NC, Papadopoulos N, Liu B et al (1994) Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 371:75–80 De Jong AE, van Puijenbroek M, Hendriks Y et al (2004) Microsatellite instability, immunohistochemistry, and additional PMS2 staining in suspected hereditary nonpolyposis colorectal cancer. Clin Cancer Res 10:972–980 Gill S, Lindor NM, Burgart LJ et al (2005) Isolated loss of PMS2 expression in colorectal cancers: frequency, patient age and familial aggregation. Clin Cancer Res 11:6466–6471 Hendriks YMC, Jagmohan-Changur S, van der Klift HM et al (2006) Heterozygous mutations in PMS2 cause hereditary nonpolyposis colorectal carcinoma (Lynch syndrome). Gastoenterology 130:312–322 Clendenning M, Hampel H, LaJeunesse J et al (2006) Long-range PCR facilitates the identification of PMS2-specific mutations. Hum Mutat 27:490–495 Talbot IC, Burt R, Järvinen H, Thomas G (2000) Familial adenomatous polyposis. In: Hamilton SR, Aaltonen (eds) WHO classification of tumours. Pathology and genetics tumours of the digestive system. IARC Press, Lyon, pp 120–125 Galiatsatos P, Foulkes WD (2006) Familial adenomatous polyposis. Am J Gastroenterol 101:385–398 Fallen T, Wilson M, Morlan B, Linder NM (2006) Desmoid tumors – a characterization of patients seen at Mayo Clinic 1976–1999. Fam Cancer 5:191–194 Tomoda C, Miyauchi A, Uruno T et al (2004) Cribriform-morular variant of papillary thyroid carcinoma: clue to early detection of familial adenomatous polyposis-associated colon cancer. World J Surg 28:886–889 Cetta F, Montalto G, Gori M et al (2000) Germline mutations of the APC gene in patients with familial adenomatous polyposis-associated thyroid carcinoma: results from a European cooperative study. J Clin Endocrinol Metab 85:286–292 Aretz S, Koch A, Uhlhaas S et al (2006) Should children at risk for familial adenomatous polyposis be screened for hepatoblastoma and children with apparently sporadic hepatoblastoma be screened for APC germline mutations? Pediatr Blood Cancer 47:811–818 Stolte M, Vieth M, Ebert MP (2003) High-grade dysplasia in sporadic fundic gland polyps: clinically relevant or not? Eur J Gastroenterol Hepatol 15:1153–1156 Attard TM, Cuffari C, Tajouri T et al (2004) Multicenter experience with upper gastrointestinal polyps in pediatric patients with familial adenomatous polyposis. Am J Gastroenterol 99:681–686 Montgomery E, Torbenson MS, Kaushal M et al (2002) Beta-catenin immunohistochemistry separates mesenteric fibromatosis from gastrointestinal stromal tumor and sclerosing mesenteritis. Am J Surg Pathol 26:1296–1301 Lynch HT, Shaw TG, Lynch JF (2004) Inherited predisposition to cancer: a historical overview. Am J Med Genet C Semin Med Genet 129:5–22 Al-tassan N, Chmiel NH, Maynard J et al (2002) Inherited variants of MYH associated with somatic G:C→T: a mutations in colorectal tumors. Nat Genet 30:227–232 Sieber OM, Lipton L, Crabtree M et al (2003) Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med 348:791–799 Aretz S, Uhlhaas S, Goergens H et al (2006) MUTYH-associated polyposis: 70 of 71 patients with biallelic mutations present with attenuated or atypical phenotype. Int J Cancer 119:807–814 Lipton L, Halford SE, Johnson V et al (2003) Carcinogenesis in MYH-associated polyposis follows a distinct genetic pathway. Cancer Res 63:7595–7599 Di Gregorio C, Frattini M, Maffei S et al (2006) Immunohistochemical expression of MYH protein can be used to identify patients with MYH-associated polyposis. Gastroenterology 131:439–444 Munitz MI (1986) Polyposis syndromes. In: Ott DJ, Wu WC (eds) Polypoid diseases of the colon, chap. 8. Urban & Schwarzenberg, Baltimore Dachman AH, BuckJL, Burke AP, Sobin LH (1989) Cronkhite-Canada syndrome: radiologic features. Gastrointest Radiol 14:285–290 Gorlin RJ, Cohen MM, Condon LM, Burke BA (1992) Bannayan-Riley-Ruvalcaba syndrome. Am J Med Genet 44:307–314 Jass JR, Williams CB, Bussey HJR, Morson BC (1988) Juvenile polyposis: a precancerous condition. Histopathology 13:619–630 Salem OS, Steck WD (1983) Cowden’s disease (multiple hamartoma and neoplasia syndrome). A case report and review of the English literature. J Am Acad Dermatol 8:686–696 Starink TM, van der Veen JPW, Arwert F et al (1986) The Cowden syndrome: a clinical and genetic study in 21 patients. Clin Genet 29:222–233 Cohen PR (1992) Genodermatoses with malignant potential. Am Fam Physician 46:1479–1486 Sweet K, Willis J, Zhou XP et al (2005) Molecular classification of patients with unexplained hamartomatous and hyperplastic polyposis. JAMA 294:2498–500 Peutz JLA (1921) Over een zeer merkwaardige, gecombineerde familiaire polyposis van de slijmliezen van den tractus intestinalis met die van de neuskeelholte en gepaard met eigenaardige pigmentaties van huid-en slijmvliezen. Ned Maandschr v Gen 10:134–146 Jeghers H, McKusick VA, Katz KH (1949) Generalized intestinal polyposis and melanin spots of the oral mucosa, lips and digits; a syndrome of diagnostic significance. N Engl J Med 241:993–1005 Tomlinson IP, Houlston RS (1997) Peutz-Jeghers syndrome. J Med Genet 34:1007–1011 Buck JL, Harned RK, Lichtenstein JE, Sobin LH (1992) Peutz-Jeghers syndrome. RadioGraphics 12:365–387 Spigelman AD, Phillips RKS (1994) Peutz-Jeghers syndrome. In: Phillips RKS, Spigelman AD, Thomson JPS (eds) Familial adenomatous polyposis and other polyposis syndromes. Edward Arnold, London, pp 188–202 Dippolito AD, Aburano A, Bezouska CA, Happ RA (1987) Enteritis cystica profunda in Peutz-Jeghers syndrome. Report of a case and review of the literature. Dis Colon Rectum 30:192–198 Dreyer L, Jacyk WK, du Plessis DJ (1994) Bilateral large-cell calcifying Sertoli cell tumor of the testes with Peutz-Jeghers syndrome: a case report. Pediatr Dermatol 11:335–337 Young RH (2005) Sex cord-stromal tumors of the ovary and testis: their similarities and differences with consideration of selected problems. Mod Pathol 18(S2):S81–S98 Podczaski E, Kaminski PF, Pees RC et al (1991) Peutz-Jeghers syndrome with ovarian sex cord tumor with annular tubules and cervical adenoma malignum. Gynecol Oncol 42:74–78 Hearle N, Schumacher V, Menko FH et al (2006) Frequency and spectrum of cancers in the Peutz-Jeghers syndrome. Clin Cancer Res 12:3209–3215 Wang ZJ, Ellis I, Zauber P et al (1999) Allelic imbalance at the LKB1 (STK11) locus in tumours from patients with Peutz-Jeghers’ syndrome provides evidence for a hamartoma-(adenoma)-carcinoma sequence. J Pathol 188:9–13 Westerman A, Entius M, de Baar E et al (1999) Peutz-Jeghers syndrome: 78-year follow-up of the original family. Lancet 353:1211–1215 Aaltonen LA (2000) Hereditary intestinal cancer. Cancer Biol 10:289–298 Morson BC (1962) Some peculiarities in the histology of intestinal polyps. Dis Colon Rectum 5:337–344 Veale AM, McColl I, Bussey HJ, Morson BC (1966) Juvenile polyposis coli. J Med Genet 3:5–16 Atard TM, Young RJ (2006) Diagnosis and management of gastrointestinal polyps. Gastroenterol Nurs 29:16–22 Fulcheri E, Baracchini P, Pagani A et al (1991) Significance of the smooth muscle cell component in Peutz–Jeghers and juvenile polyposis. Hum Pathol 22:1136–1140 Coburn MC, Pricolo VE, DeLuca FG, Bland KI (1995) Malignant potential in intestinal juvenile polyposis syndromes. Ann Surg Oncol 2:386–391 Giardiello FM, Hamilton SR, Kern SE et al (1991) Colorectal neoplasia in juvenile polyposis or juvenile polyps. Arch Dis Child 66:971–975 Walpole IR, Cullity G (1989) Juvenile polyposis: a case with early presentation and death attributable to adenocarcinoma of the pancreas. Am J Med Genet 32:1–8 Houlston R, Bevan S, Williams A et al (1998) Mutations in DPC4 (SMAD4) cause juvenile polyposis syndrome, but only account for a minority of cases. Hum Mol Genet 7:1907–1912 Howe JR, Bair JL, Sayed MG et al (2001) Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat Genet 28:184–187 Sayed MG, Ahmed AF, Ringold JR et al (2002) Germline SMAD4 or BMPR1A mutations and phenotype of juvenile polyposis. Ann Surg Oncol 9:901–906 Schreibman IR, Baker M, Amos C, McGarrity TJ (2005) The hamartomatous polyposis syndromes: a clinical and molecular review. Am J Gastroenterol 100:476–490 Marsh DJ, Coulon V, Lunetta KL et al (1998) Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum Mol Genet 7:507–515 Hahn H, Wicking C, Zaphiropoulous PG et al (1996) Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 85:841–851 Reifenberger G, Wiestler OD, Chenvix-Trench G (2000) Naevoid basal cell carcinoma syndrome. In: Kleihues P, Cavanee WK (eds) Tumors of the nervous system. IARCC Press, Lyon, pp 240–241 Woodford-Richens K, Bevan S, Churchman M et al (2000) Analysis of genetic and phenotypic heterogeneity in juvenile polyposis. Gut 46:656–660 Whitelaw SC, Murday VA, Tomlinson IP et al (1997) Clinical and molecular features of the hereditary mixed polyposis syndrome. Gastroenterology 112:327–334 Rozen P, Samuel Z, Brazowski E (2002) A prospective study of the clinical, genetic, screening, and pathologic features of a family with hereditary mixed polyposis syndrome. Am J Gastroenterol 98:2317–2320 Thomas H, Whitelaw S, Cottrell S et al (1996) Genetic mapping of hereditary mixed polyposis syndrome to chromosome 6q. Am J Hum Genet 58:770–776 Farrington SM, Tenesa A, Barnetson R et al (2005) Germline susceptibility to colorectal cancer due to base-excision repair gene defects. Am J Hum Genet 77:112–119 Jaeger EEM, Woodford-Richens KL et al (2003) An ancestral Ashkenazi haplotype at the HMPS/CRAC1 locus on 15q13–q14 is associated with hereditary mixed polyposis syndrome. Am J Hum Genet 72: 1261–1267 Cao X, Eu KW, Kumarasinghe MP et al (2006) Mapping of hereditary mixed polyposis syndrome (HMPS) to chromosome 10q23 by genomewide high-density single nucleotide polymorphism (SNP) scan and identification of BMPR1A loss of function. J Med Genet 43:e13 Zhou XP, Woodford-Richens K, Lehtonen R et al (2001) Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes. Am J Hum Genet 9:704–711 Torlakovic E, Snover DC (1996) Serrated adenomatous polyposis in humans. Gastroenterology 110:748–755 Chow E, Lipton L, Lynch E et al (2006) Hyperplastic polyposis syndrome: Phenotypic presentations abd the role of MBD4 and MYH. Gastroenterology 131:30–39 Young J, Jass JR (2006) The case for a genetic predisposition to serrated neoplasia in the colorectum: hypothesis and review of the literature. Cancer Epidemiol Biomarkers Prev 15:1778–1784